Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

被引：4
|
作者：
Hendrickson, Andrea E. Wahner [1 ]
Bakkum-Gamez, Jamie N. [2 ]
Couch, Fergus J. [3 ]
Ghosh, Karthik [4 ]
Boughey, Judy C. [5 ]
机构：
[1] Mayo Clin, Dept Med Oncol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[4] Mayo Clin, Dept Med, Rochester, MN USA
[5] Mayo Clin, Dept Surg, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷 / 11期
关键词：
TAMOXIFEN; CARRIERS;
D O I：
10.1245/s10434-017-5999-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3107 / 3109
页数：3
相关论文
共 50 条
  • [31] Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient
    Randall, TC
    Bell, KA
    Rebane, BA
    Rubin, SC
    Boyd, J
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 432 - 434
  • [32] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
    Thomassen, Mads
    Hansen, Thomas V. O.
    Borg, Ake
    Lianee, Henriette Theilmann
    Wikman, Friedrik
    Pedersen, Inge Sokilde
    Bisgaard, Marie Luise
    Nielsen, Finn C.
    Kruse, Torben A.
    Gerdes, Anne-Marie
    [J]. ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
  • [33] BRCA1 and BRCA2 predisposing mutations in breast or ovarian cancer probands at risk of genetic predisposition
    Sidoni, T.
    Midulla, C.
    Mazzoli, M.
    Paris, I
    Ronzino, G.
    Tomao, S.
    Di Seri, L.
    Scambia, G.
    Cortesi, E.
    Frati, L.
    Screpanti, I
    Gulino, A.
    Marchetti, P.
    Giannini, G.
    Ricevuto, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI35 - XI35
  • [34] Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
    Rashid, Muhammad U.
    Zaidi, Anbreen
    Torres, Diana
    Sultan, Faisal
    Benner, Axel
    Naqvi, Bilal
    Shakoori, Abdul R.
    Seidel-Renkert, Antje
    Farooq, Humirah
    Narod, Steven
    Amin, Asim
    Hamann, Ute
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2832 - 2839
  • [35] BRCA1 and BRCA2 predisposing mutations in breast or ovarian cancer probands at risk of genetic predisposition
    Sidoni, T.
    Ristori, E.
    Midulla, C.
    Mazzoli, M.
    Ronzino, G.
    Paris, I.
    Capalbo, C.
    Mazzei, N.
    Tomao, S.
    Di Seri, L.
    Scambia, G.
    Cortesi, E.
    Frati, L.
    Screpanti, I.
    Gulino, A.
    Marchetti, P.
    Giannini, G.
    Ricevuto, E.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 38 - 38
  • [36] Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed Opportunities
    Herman, Jonathan
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 116 (02): : 440 - 441
  • [37] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    [J]. SCIENCE, 2003, 302 (5645) : 643 - 646
  • [38] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Ramus, SJ
    Friedman, LS
    Gayther, SA
    Ponder, BAJ
    Bobrow, LG
    vanderLooji, M
    Papp, J
    Olah, E
    [J]. NATURE GENETICS, 1997, 15 (01) : 14 - 15
  • [39] Prevalence of Germline BRCA1 and BRCA2 Deleterious Mutations in Brazilian Patients with High-Risk of Breast and Ovarian Cancer.
    Diz, M. D. P. E.
    Escobar, K. A.
    Guindalini, R. S. C.
    Pasini, F. S.
    Snitkoyiski, M. L.
    Maistro, S.
    Hoff, P. M. G.
    Federico, M. H. H.
    [J]. CANCER RESEARCH, 2011, 71
  • [40] Germline Mutations of BRCA1 and BRCA2 in Korean Breast and/or Ovarian Cancer Families
    Kang, Hio Chung
    Kim, Il-Jin
    Park, Jae-Hyun
    Kwon, Hyuk-Jun
    Won, Yong-Jin
    Heo, Seung Chul
    Lee, Sang-Yon
    Kim, Kyung-Hee
    Shin, Yong
    Noh, Dong Young
    Yang, Dae-Hyun
    Choe, Kuk Jin
    Lee, Bong Hwa
    Kang, Soon Beom
    Park, Jae-Gahb
    [J]. HUMAN MUTATION, 2002, 20 (03) : 235
12345